The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Biopharmaceuticals Market Research Report 2024
Synopsis
The global Pet Biopharmaceuticals market was valued at US$ 14270 million in 2023 and is anticipated to reach US$ 19590 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 47%.
This report aims to provide a comprehensive presentation of the global market for Pet Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Biopharmaceuticals.
Report Scope
The Pet Biopharmaceuticals market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Biopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
Segment by Type
Antiparasitic
Biological Products
Antibacterial
Others
Segment by Application
Prevention
Treatment
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Biopharmaceuticals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pet Biopharmaceuticals market was valued at US$ 14270 million in 2023 and is anticipated to reach US$ 19590 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 47%.
This report aims to provide a comprehensive presentation of the global market for Pet Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Biopharmaceuticals.
Report Scope
The Pet Biopharmaceuticals market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Biopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
Segment by Type
Antiparasitic
Biological Products
Antibacterial
Others
Segment by Application
Prevention
Treatment
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Biopharmaceuticals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Biopharmaceuticals Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antiparasitic
1.2.3 Biological Products
1.2.4 Antibacterial
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pet Biopharmaceuticals Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Prevention
1.3.3 Treatment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Biopharmaceuticals Market Perspective (2019-2030)
2.2 Pet Biopharmaceuticals Growth Trends by Region
2.2.1 Global Pet Biopharmaceuticals Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pet Biopharmaceuticals Historic Market Size by Region (2019-2024)
2.2.3 Pet Biopharmaceuticals Forecasted Market Size by Region (2025-2030)
2.3 Pet Biopharmaceuticals Market Dynamics
2.3.1 Pet Biopharmaceuticals Industry Trends
2.3.2 Pet Biopharmaceuticals Market Drivers
2.3.3 Pet Biopharmaceuticals Market Challenges
2.3.4 Pet Biopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Biopharmaceuticals Players by Revenue
3.1.1 Global Top Pet Biopharmaceuticals Players by Revenue (2019-2024)
3.1.2 Global Pet Biopharmaceuticals Revenue Market Share by Players (2019-2024)
3.2 Global Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pet Biopharmaceuticals Revenue
3.4 Global Pet Biopharmaceuticals Market Concentration Ratio
3.4.1 Global Pet Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Biopharmaceuticals Revenue in 2023
3.5 Pet Biopharmaceuticals Key Players Head office and Area Served
3.6 Key Players Pet Biopharmaceuticals Product Solution and Service
3.7 Date of Enter into Pet Biopharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Biopharmaceuticals Breakdown Data by Type
4.1 Global Pet Biopharmaceuticals Historic Market Size by Type (2019-2024)
4.2 Global Pet Biopharmaceuticals Forecasted Market Size by Type (2025-2030)
5 Pet Biopharmaceuticals Breakdown Data by Application
5.1 Global Pet Biopharmaceuticals Historic Market Size by Application (2019-2024)
5.2 Global Pet Biopharmaceuticals Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pet Biopharmaceuticals Market Size (2019-2030)
6.2 North America Pet Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pet Biopharmaceuticals Market Size by Country (2019-2024)
6.4 North America Pet Biopharmaceuticals Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Biopharmaceuticals Market Size (2019-2030)
7.2 Europe Pet Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pet Biopharmaceuticals Market Size by Country (2019-2024)
7.4 Europe Pet Biopharmaceuticals Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Biopharmaceuticals Market Size (2019-2030)
8.2 Asia-Pacific Pet Biopharmaceuticals Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2019-2024)
8.4 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Biopharmaceuticals Market Size (2019-2030)
9.2 Latin America Pet Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pet Biopharmaceuticals Market Size by Country (2019-2024)
9.4 Latin America Pet Biopharmaceuticals Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Biopharmaceuticals Market Size (2019-2030)
10.2 Middle East & Africa Pet Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2019-2024)
10.4 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Pet Biopharmaceuticals Introduction
11.1.4 Zoetis Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Introduction
11.2.4 Boehringer Ingelheim Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Pet Biopharmaceuticals Introduction
11.3.4 Merck Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Elanco
11.4.1 Elanco Company Detail
11.4.2 Elanco Business Overview
11.4.3 Elanco Pet Biopharmaceuticals Introduction
11.4.4 Elanco Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.4.5 Elanco Recent Development
11.5 Virbac
11.5.1 Virbac Company Detail
11.5.2 Virbac Business Overview
11.5.3 Virbac Pet Biopharmaceuticals Introduction
11.5.4 Virbac Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.5.5 Virbac Recent Development
11.6 Dechra Veterinary Products
11.6.1 Dechra Veterinary Products Company Detail
11.6.2 Dechra Veterinary Products Business Overview
11.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Introduction
11.6.4 Dechra Veterinary Products Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.6.5 Dechra Veterinary Products Recent Development
11.7 Ceva
11.7.1 Ceva Company Detail
11.7.2 Ceva Business Overview
11.7.3 Ceva Pet Biopharmaceuticals Introduction
11.7.4 Ceva Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.7.5 Ceva Recent Development
11.8 Vetoquinol
11.8.1 Vetoquinol Company Detail
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Pet Biopharmaceuticals Introduction
11.8.4 Vetoquinol Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.8.5 Vetoquinol Recent Development
11.9 Ouro Fino Saude
11.9.1 Ouro Fino Saude Company Detail
11.9.2 Ouro Fino Saude Business Overview
11.9.3 Ouro Fino Saude Pet Biopharmaceuticals Introduction
11.9.4 Ouro Fino Saude Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.9.5 Ouro Fino Saude Recent Development
11.10 Norbrook
11.10.1 Norbrook Company Detail
11.10.2 Norbrook Business Overview
11.10.3 Norbrook Pet Biopharmaceuticals Introduction
11.10.4 Norbrook Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.10.5 Norbrook Recent Development
11.11 Jindun
11.11.1 Jindun Company Detail
11.11.2 Jindun Business Overview
11.11.3 Jindun Pet Biopharmaceuticals Introduction
11.11.4 Jindun Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.11.5 Jindun Recent Development
11.12 Chopperlvya Animal Health
11.12.1 Chopperlvya Animal Health Company Detail
11.12.2 Chopperlvya Animal Health Business Overview
11.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Introduction
11.12.4 Chopperlvya Animal Health Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.12.5 Chopperlvya Animal Health Recent Development
11.13 CAHIC
11.13.1 CAHIC Company Detail
11.13.2 CAHIC Business Overview
11.13.3 CAHIC Pet Biopharmaceuticals Introduction
11.13.4 CAHIC Revenue in Pet Biopharmaceuticals Business (2019-2024)
11.13.5 CAHIC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pet Biopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antiparasitic
Table 3. Key Players of Biological Products
Table 4. Key Players of Antibacterial
Table 5. Key Players of Others
Table 6. Global Pet Biopharmaceuticals Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Pet Biopharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Pet Biopharmaceuticals Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Pet Biopharmaceuticals Market Share by Region (2019-2024)
Table 10. Global Pet Biopharmaceuticals Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Pet Biopharmaceuticals Market Share by Region (2025-2030)
Table 12. Pet Biopharmaceuticals Market Trends
Table 13. Pet Biopharmaceuticals Market Drivers
Table 14. Pet Biopharmaceuticals Market Challenges
Table 15. Pet Biopharmaceuticals Market Restraints
Table 16. Global Pet Biopharmaceuticals Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Pet Biopharmaceuticals Market Share by Players (2019-2024)
Table 18. Global Top Pet Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2023)
Table 19. Ranking of Global Top Pet Biopharmaceuticals Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Pet Biopharmaceuticals Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pet Biopharmaceuticals Product Solution and Service
Table 23. Date of Enter into Pet Biopharmaceuticals Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pet Biopharmaceuticals Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Pet Biopharmaceuticals Revenue Market Share by Type (2019-2024)
Table 27. Global Pet Biopharmaceuticals Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Pet Biopharmaceuticals Revenue Market Share by Type (2025-2030)
Table 29. Global Pet Biopharmaceuticals Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Pet Biopharmaceuticals Revenue Market Share by Application (2019-2024)
Table 31. Global Pet Biopharmaceuticals Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Pet Biopharmaceuticals Revenue Market Share by Application (2025-2030)
Table 33. North America Pet Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Pet Biopharmaceuticals Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Pet Biopharmaceuticals Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Pet Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Pet Biopharmaceuticals Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Pet Biopharmaceuticals Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Pet Biopharmaceuticals Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Pet Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Pet Biopharmaceuticals Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pet Biopharmaceuticals Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pet Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2025-2030) & (US$ Million)
Table 48. Zoetis Company Detail
Table 49. Zoetis Business Overview
Table 50. Zoetis Pet Biopharmaceuticals Product
Table 51. Zoetis Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 52. Zoetis Recent Development
Table 53. Boehringer Ingelheim Company Detail
Table 54. Boehringer Ingelheim Business Overview
Table 55. Boehringer Ingelheim Pet Biopharmaceuticals Product
Table 56. Boehringer Ingelheim Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 57. Boehringer Ingelheim Recent Development
Table 58. Merck Company Detail
Table 59. Merck Business Overview
Table 60. Merck Pet Biopharmaceuticals Product
Table 61. Merck Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Elanco Company Detail
Table 64. Elanco Business Overview
Table 65. Elanco Pet Biopharmaceuticals Product
Table 66. Elanco Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 67. Elanco Recent Development
Table 68. Virbac Company Detail
Table 69. Virbac Business Overview
Table 70. Virbac Pet Biopharmaceuticals Product
Table 71. Virbac Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 72. Virbac Recent Development
Table 73. Dechra Veterinary Products Company Detail
Table 74. Dechra Veterinary Products Business Overview
Table 75. Dechra Veterinary Products Pet Biopharmaceuticals Product
Table 76. Dechra Veterinary Products Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 77. Dechra Veterinary Products Recent Development
Table 78. Ceva Company Detail
Table 79. Ceva Business Overview
Table 80. Ceva Pet Biopharmaceuticals Product
Table 81. Ceva Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 82. Ceva Recent Development
Table 83. Vetoquinol Company Detail
Table 84. Vetoquinol Business Overview
Table 85. Vetoquinol Pet Biopharmaceuticals Product
Table 86. Vetoquinol Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 87. Vetoquinol Recent Development
Table 88. Ouro Fino Saude Company Detail
Table 89. Ouro Fino Saude Business Overview
Table 90. Ouro Fino Saude Pet Biopharmaceuticals Product
Table 91. Ouro Fino Saude Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 92. Ouro Fino Saude Recent Development
Table 93. Norbrook Company Detail
Table 94. Norbrook Business Overview
Table 95. Norbrook Pet Biopharmaceuticals Product
Table 96. Norbrook Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 97. Norbrook Recent Development
Table 98. Jindun Company Detail
Table 99. Jindun Business Overview
Table 100. Jindun Pet Biopharmaceuticals Product
Table 101. Jindun Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 102. Jindun Recent Development
Table 103. Chopperlvya Animal Health Company Detail
Table 104. Chopperlvya Animal Health Business Overview
Table 105. Chopperlvya Animal Health Pet Biopharmaceuticals Product
Table 106. Chopperlvya Animal Health Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 107. Chopperlvya Animal Health Recent Development
Table 108. CAHIC Company Detail
Table 109. CAHIC Business Overview
Table 110. CAHIC Pet Biopharmaceuticals Product
Table 111. CAHIC Revenue in Pet Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 112. CAHIC Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Biopharmaceuticals Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pet Biopharmaceuticals Market Share by Type: 2023 VS 2030
Figure 3. Antiparasitic Features
Figure 4. Biological Products Features
Figure 5. Antibacterial Features
Figure 6. Others Features
Figure 7. Global Pet Biopharmaceuticals Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Pet Biopharmaceuticals Market Share by Application: 2023 VS 2030
Figure 9. Prevention Case Studies
Figure 10. Treatment Case Studies
Figure 11. Pet Biopharmaceuticals Report Years Considered
Figure 12. Global Pet Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Pet Biopharmaceuticals Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pet Biopharmaceuticals Market Share by Region: 2023 VS 2030
Figure 15. Global Pet Biopharmaceuticals Market Share by Players in 2023
Figure 16. Global Top Pet Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Pet Biopharmaceuticals Revenue in 2023
Figure 18. North America Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Pet Biopharmaceuticals Market Share by Country (2019-2030)
Figure 20. United States Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pet Biopharmaceuticals Market Share by Country (2019-2030)
Figure 24. Germany Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pet Biopharmaceuticals Market Share by Region (2019-2030)
Figure 32. China Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pet Biopharmaceuticals Market Share by Country (2019-2030)
Figure 40. Mexico Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pet Biopharmaceuticals Market Share by Country (2019-2030)
Figure 44. Turkey Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Pet Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Zoetis Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 48. Merck Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 49. Elanco Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 50. Virbac Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 51. Dechra Veterinary Products Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 52. Ceva Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 53. Vetoquinol Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 54. Ouro Fino Saude Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 55. Norbrook Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 56. Jindun Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 57. Chopperlvya Animal Health Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 58. CAHIC Revenue Growth Rate in Pet Biopharmaceuticals Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
